Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Private healthcare services group Mediclinic reported higher revenue and margins in the first half of the year, following a recovery in patient activity.
For the six months ended 30 September 2021, revenue grew 12% year-on-year, and was up 4% across all three divisions from hte pre-Covid period.
Hirslanden and Mediclinic Middle East delivered volumes in excess of pre-pandemic levels.
There was a material recovery in earnings before interest, taxes, depreciation, and amortisation, or EBITDA margin, to around 15.5% from 12.1%.
'Mediclinic Southern Africa has continued to treat a significant number of COVID-19 patients, while addressing the demand for urgent and elective non-COVID-19 care,' the company said.
'The strong first-half delivered by Mediclinic Middle East, combined with a robust performance at Hirslanden in Switzerland, positions us well heading into the second-half of the year,' it added.